Detection of microbial products by host inflammasomes is an important mechanism of innate immune surveillance. Inflammasomes activate the caspase-1 (CASP1) protease, which processes the cytokines interleukin (IL)-1b and IL-18, and initiates a lytic host cell death called pyroptosis 1 . To identify novel CASP1 functions in vivo, we devised a strategy for cytosolic delivery of bacterial flagellin, a specific ligand for the NAIP5 (NLR family, apoptosis inhibitory protein 5)/NLRC4 (NLR family, CARD-domain-containing 4) inflammasome [2] [3] [4] . Here we show that systemic inflammasome activation by flagellin leads to a loss of vascular fluid into the intestine and peritoneal cavity, resulting in rapid (less than 30 min) death in mice. This unexpected response depends on the inflammasome components NAIP5, NLRC4 and CASP1, but is independent of the production of IL-1b or IL-18. Instead, inflammasome activation results, within minutes, in an 'eicosanoid storm'-a pathological release of signalling lipids, including prostaglandins and leukotrienes, that rapidly initiate inflammation and vascular fluid loss. Mice deficient in cyclooxygenase-1, a critical enzyme in prostaglandin biosynthesis, are resistant to these rapid pathological effects of systemic inflammasome activation by either flagellin or anthrax lethal toxin. Inflammasome-dependent biosynthesis of eicosanoids is mediated by the activation of cytosolic phospholipase A 2 in resident peritoneal macrophages, which are specifically primed for the production of eicosanoids by high expression of eicosanoid biosynthetic enzymes. Our results therefore identify eicosanoids as a previously unrecognized cell-type-specific signalling output of the inflammasome with marked physiological consequences in vivo.
NAIP/NLRC4 inflammasome activation is critical for innate immune detection and defence against multiple bacterial pathogens in mice [5] [6] [7] . This resistance to infection, as well as the inflammasomedependent response to systemic endotoxin, does not require IL-1b or IL-18 (refs 5, 8, 9) , suggesting a critical role for pyroptosis and/or other inflammasome functions [9] [10] [11] [12] . In this study we sought to identify previously unknown in vivo signalling outputs of the NAIP5/NLRC4 inflammasome. To activate NAIP5/NLRC4 selectively, we delivered Legionella pneumophila flagellin (FlaA) to the cytosol by the fusion of FlaA to the amino-terminal domain of Bacillus anthracis lethal factor (LFn), which mediates cytosolic delivery through the anthrax protective antigen (PA) channel 2,3 . As expected, PA plus LFn-FlaA (here called FlaTox), but not PA or LFn-FlaA alone, activated the NAIP5/NLRC4 inflammasome in bone-marrow-derived macrophages (BMDMs), as indicated by cleavage of CASP1, release of lactate dehydrogenase and secretion of IL-1b ( Supplementary Fig. 1 ). Inflammasome activation was abrogated in Casp1 2/2 , Naip5 2/2 and Nlrc4 2/2 BMDMs ( Supplementary Fig. 1b ). A mutant form of FlaTox (FlaTox(AAA)), which is recognized by Toll-like receptor (TLR)-5 but not by NAIP5 (ref. 4), did not activate pyroptosis ( Supplementary Fig. 1a ).
We then determined the effect of FlaTox administration in vivo. Intravenous or intraperitoneal delivery of FlaTox killed mice rapidly, causing symptoms within 15 min and a mean time to death of about 30 min at saturating intravenous doses ( Fig. 1a and Supplementary Fig. 1f ). For subsequent experiments we administered a sublethal intraperitoneal dose. FlaTox-treated mice rapidly developed diarrhoea; however, histological analysis ( Supplementary Fig. 2 and data not shown) after 30 min revealed no signs of pathology. Instead, we found fluid accumulation in the peritoneal cavity and intestine, but not in the kidneys or lungs ( Supplementary Fig. 3 ). This fluid was lost from the blood, as the percentage volume of red blood cells (haematocrit) increased to 70-80% (normal 45-50%) within 30-40 min after FlaTox injection ( Fig. 1b ). As haematocrit rose, body temperature dropped, but with delayed kinetics (Fig. 1b) . Haemoconcentration was the earliest pathological event that we detected after treatment with FlaTox, and is probably the primary cause of the ensuing circulatory collapse, hypothermia and death.
We found that only the complete toxin, rather than individual subunits or FlaTox(AAA), induced hypothermia and increased haematocrit ( Fig. 1c, d and Supplementary Fig. 4a ), showing that TLR signalling activated by flagellin or bacterial contaminants is insufficient to cause pathology. Nlrc4 2/2 mice were completely protected at all doses and time points tested (Fig. 1e , f and data not shown). Naip5 2/2 and Casp1 2/2 mice were completely protected in survival experiments ( Supplementary Fig. 4b ), but they showed a delayed haemoconcentration and hypothermic response ( Fig. 1e , f). The moderate response of Naip5 2/2 mice may be due to recognition of flagellin by NAIP6 (refs 2, 3). Mice lacking tumour necrosis factor (LTa/LTb/TNFa 2/2 ) or IL-1b and IL-18 were as sensitive as wild-type (B6) mice ( Fig. 1g , h and Supplementary Fig. 4b-d ), ruling out an essential role for these cytokines in FlaTox-induced pathologies.
To identify the cell type(s) that respond to FlaTox, we generated bone marrow chimaeras by using susceptible wild-type (B6) mice and resistant Nlrc4 2/2 mice. Nlrc4 2/2 mice reconstituted with wild-type bone marrow were completely susceptible to FlaTox ( Fig. 2a, b ). Wild-type mice reconstituted with Nlrc4 2/2 bone marrow also responded to FlaTox, but with delayed kinetics. These results suggest that at least two cell populations respond to FlaTox: first, radiosensitive haematopoietic cells that are necessary and sufficient for the early response to FlaTox (0-30 min), and second, radio-resistant cells that respond after 30 min. Hereafter we focused on the early haematopoietic response (EHR).
The EHR was intact in mice deficient in mast cells, lymphocytes and neutrophils ( Supplementary Fig. 5 ). By contrast, wild-type mice depleted of macrophages by using clodronate-loaded liposomes were almost completely protected from the EHR (Fig. 2c, d) . Similarly, depletion of CD11b 1 cells in FVB:CD11b-DTR mice conferred protection ( Fig. 2e, f) . Flow cytometric analysis revealed almost complete ablation of CD11b/F4-80 hi resident peritoneal macrophages by both treatments ( Supplementary Fig. 6a ), whereas depletion of splenic and lamina propria macrophages was only partial (clodronate) or not observed (CD11b-DTR) ( Supplementary Fig. 6c, d ). We therefore speculated that resident peritoneal macrophages might mediate responsiveness to FlaTox. Indeed, Nlrc4 2/2 mice injected with wildtype resident peritoneal cells became sensitive to FlaTox (Fig. 2g ). By contrast, spleen or bone marrow cells did not transfer responsiveness; unexpectedly, neither did wild-type thioglycollate-elicited peritoneal macrophages or BMDMs ( Fig. 2g and Supplementary Fig. 6e ). These data demonstrate a unique and critical function for resident peritoneal macrophages in the inflammasome-dependent in vivo response to FlaTox.
We speculated that peritoneal macrophages might initiate the EHR through the inflammasome-dependent secretion of a previously unidentified factor. Eicosanoids are paracrine signalling lipids that are crucial for the activation of inflammation and host defence, and can induce vascular permeability, vasodilation and leukocyte chemotaxis [13] [14] [15] [16] . Eicosanoids are synthesized when arachidonic acid released from cell membranes by phospholipases is converted into prostaglandins (PGs) and thromboxanes downstream of the cyclooxygenases (COX-1 and COX-2) or into hydroxyeicosatetraenoic acids (HETEs) and leukotrienes (LTs) downstream of the lipoxygenases (12/15-LOX and 5-LOX) ( Supplementary Fig. 7 ). Direct intraperitoneal injection of prostaglandins leads to diarrhoea and fluid accumulation in the gut 17, 18 , both hallmarks of FlaTox-induced pathology.
We therefore speculated that resident peritoneal macrophages, the specific cells required for the EHR (Fig. 2) , produce eicosanoids in response to inflammasome activation. Using liquid chromatographytandem mass spectrometry (LC-MS/MS) lipidomic analysis and enzyme immunoassay, we detected rapid biosynthesis of numerous COX-dependent and LOX-dependent eicosanoids including LTB 4 , PGE 2 and cysteinyl LTs in supernatants of peritoneal lavage cells treated ex vivo with FlaTox, whereas the FlaTox(AAA) mutant elicited a much weaker response ( Fig. 3 and Supplementary Fig. 8a, b ). Moreover, eicosanoid induction required NAIP5, NLRC4 and CASP1 ( Fig. 3b and Supplementary Fig. 8c ). LTB 4 /PGE 2 induction by PA or LFn-FlaA alone was equivalent to stimulation with FlaTox(AAA) or lipopolysaccharide, further demonstrating that TLR signalling cannot account for their rapid biosynthesis ( Fig. 3c and Supplementary . e, f, CD11b 1 cell-depleted FVB:CD11b-DTR mice (n 5 6-7). g, Nlrc4 2/2 host mice injected intraperitoneally with 10 7 resident (Res.) or thioglycollate-elicited (Thio.) peritoneal cells or BMDMs of indicated genotype. Rectal temperature was measured 30 min after intraperitoneal injection of FlaTox (8 mg g 21 PA 1 4 mg g 21 LFn-FlaA). Data shown are pooled from multiple experiments (g) or are representative of at least three independent experiments (a-f). Error bars in a denote s.e.m. Two asterisks, P , 0.01; three asterisks, P 5 0.001 (Mann-Whitney test). Fig. 8b ). The flagellated intracellular pathogen Salmonella enterica serovar Typhimurium (S. typhimurium) also elicited inflammasomedependent eicosanoid biosynthesis in a similar manner to FlaTox ( Fig. 3d and Supplementary Fig. 8d ), demonstrating that this pathway is activated during live infection.
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Similarly to the ex vivo results, LC-MS/MS analysis of peritoneal lavage fluid from mice treated with FlaTox for 20 min revealed robust inflammasome-dependent eicosanoid biosynthesis in vivo (Supplementary Fig. 9 ). Some residual eicosanoid biosynthesis (particularly of PGE 2 ) was observed after treatment with FlaTox(AAA). This residual response is probably due to bacterial contaminants (for example lipopolysaccharide) activating peritoneal cells other than macrophages, because macrophages did not produce PGE 2 in response to stimulation for 30 min with lipopolysaccharide or FlaTox(AAA) (Fig. 3c ). However, because this residual response did not produce symptoms (Fig. 1c, d) and eicosanoids have only paracrine effects, the FlaTox-induced pathology is probably a localized response mediated by resident peritoneal macrophages and/or the synergistic effects of multiple eicosanoids. FlaTox did not result in the detectable production of anti-inflammatory lipoxins 19 . Taken together, our results show that inflammasome activation results in an 'eicosanoid storm' ex vivo and in vivo, characterized by the broad biosynthesis of both LOX and COX products, with a bias towards pro-inflammatory lipids.
How does inflammasome activation induce eicosanoid biosynthesis? Although cells express several initiating A 2 phospholipases, Ca 21 -dependent cytosolic phospholipase A 2 (cPLA 2 ) accounts for nearly all eicosanoid biosynthesis in peritoneal macrophages treated with a Ca 21 ionophore 20 . Inhibition of cPLA 2 also blocked LTB 4 and PGE 2 production but not pyroptosis in response to FlaTox ( Fig. 4a and Supplementary Fig. 8e ). An increase in intracellular Ca 21 is both necessary and sufficient for cPLA 2 activation 21 ; notably, the earliest detectable CASP1-dependent events in BMDMs infected with S. typhimurium are the formation of plasma membrane pores and the influx of Ca 21 (refs 22, 23) . We observed that CASP1-dependent Ca 21 influx, comparable in magnitude to an ionomycin control ( Supplementary Fig. 10 ), preceded cell lysis (79 6 29 s before the onset of membrane blebbing) in resident peritoneal macrophages (Fig. 4b, c ). This Ca 21 influx seems to be critical for eicosanoid biosynthesis but dispensable for pyroptosis in response to FlaTox, because the intracellular Ca 21 chelator bis-(o-aminophenoxy)ethane-N,N,N9,N9-tetraacetic acid acetoxymethyl ester (BAPTA-AM) inhibited PGE 2 and LTB 4 production without blocking lactate dehydrogenase (LDH) release ( Fig. 4d and Supplementary Fig. 8f ). Macrophages treated with glycine to inhibit pyroptosis 23 still produced PGE 2 in response to FlaTox, whereas cells lysed by digitonin or H 2 O 2 did not, further indicating that eicosanoid production and cell lysis are separable events ( Supplementary Fig. 11 ). Taken together, our results suggest a model ( Supplementary Fig. 12 ) in which CASP1 activation results in rapid Ca 21 flux (Fig. 4b ) that leads to cPLA 2 activation and downstream eicosanoid biosynthesis. Identification of a CASP1 substrate required for Ca 21 influx is an important, but technically challenging, area for future research because proteomic studies to identify novel substrates of CASP1 (refs 24-26) have so far yielded limited insight.
Although cPLA 2 activity is regulated primarily by Ca 21 influx, its activity can be enhanced by mitogen-activated protein kinase (MAPK)-dependent phosphorylation 21 . We wondered whether TLR signalling activated by FlaTox (FlaA or bacterial contaminants) might enhance cPLA 2 activity through downstream MAPKs. Indeed, cPLA 2 in resident peritoneal cells was phosphorylated after treatment with FlaTox, and this was inflammasome-independent but Myd88/Trifdependent ( Fig. 4e) . Accordingly, LTB 4 production in response to FlaTox was partly attenuated in Myd88/Trif 2/2 cells, and Myd88/ Trif 2/2 mice were partly protected in vivo ( Supplementary Fig. 13 ). Thus, although inflammasome-dependent Ca 21 flux is both sufficient and necessary for eicosanoid production in response to FlaTox, TLR signalling, which is expected to accompany natural infection, can synergize with inflammasome activation to produce maximal responses.
We further investigated the basis for the cell-type specificity of inflammasome-dependent eicosanoid biosynthesis. Consistent with the inability of BMDMs to transfer responsiveness to FlaTox in vivo (Fig. 2g) , we observed no eicosanoid production by LC-MS/MS in BMDMs treated with FlaTox for 30 min (Fig. 3a) . Even at 2 h after treatment, when most BMDMs have undergone pyroptosis, we could not detect PGE 2 or LTB 4 production (Fig. 4f, g and Supplementary Fig.  8g, h) . Cox1, Alox12/15 and Alox5, which encode key enzymes required for eicosanoid biosynthesis, are expressed at much higher levels (10-1,000-fold) in CD11b/F4-80 hi resident peritoneal macrophages than in BMDMs or thioglycollate-elicited CD11b/F4-80 hi cells (Fig. 4h-j) . Resident peritoneal macrophages are therefore uniquely primed for eicosanoid responses. Most characterization of inflammasomes has relied on BMDMs, which perhaps explains why a link to eicosanoid biosynthesis has not been described. We speculate that the primed state of resting peritoneal macrophages may be a general characteristic of resident macrophages guarding sites of pathogen entry; it will be important to further explore the lineage-specific regulation of inflammasome function in vivo.
To test whether eicosanoids contribute to FlaTox-induced pathology, we injected B6;129P2.Cox1 2/2 mice and littermate controls with FlaTox, and found that the EHR was significantly attenuated in these mice (P , 0.0007; Fig. 4k , l) despite intact pyroptosis ( Supplementary  Fig. 14) . As expected, given that FlaTox induces the broad biosynthesis 
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of both COX-1-dependent and COX-1-independent eicosanoids, the role of COX-1 was masked at high doses of FlaTox or at later time points (data not shown), suggesting a contribution of COX-1independent eicosanoids or other unidentified factors. In confirmation of the results with Cox1 2/2 mice, chemical inhibition of COX-1 protected mice from a low dose of FlaTox ( Supplementary Fig. 15 ). Inhibition of the inducible enzyme COX-2 or the genetic deletion of Alox5 had no effect, although their contribution may be masked by functional redundancy of downstream eicosanoids (Supplementary Fig. 15 ). These data link the production of COX-1-dependent eicosanoids to the pathology associated with in vivo delivery of FlaTox, which is consistent with earlier reports that purified prostaglandins are sufficient to cause fluid accumulation and diarrhoea 17, 18 .
We speculated that other inflammasomes might also lead to eicosanoid production in vivo. For example, anthrax lethal toxin activates the NLRP1B inflammasome 27 , resulting in a rapid (but transient and non-lethal) hypothermic response 28 . Because C57BL/6 mice express a non-functional allele of Nlrp1b (Nlrp1b R ), we injected Cox1 1/1 mice expressing the sensitive 129 allele of Nlrp1b (Nlrp1b S ).
These mice developed diarrhoea, decreased body temperature and an inflammasome-dependent increase in haematocrit (Fig. 4m, n) . As in FlaTox-treated mice, deletion of Cox1 attenuated these early pathologies of lethal toxin (Fig. 4m, n) , indicating that this naturally occurring bacterial toxin activates a similar, though non-lethal, inflammasome pathway in mice.
Whereas many cellular immune responses require de novo transcription, the NAIP5/NLRC4 and NLRP1B inflammasomes assemble from preformed protein components to activate a proteolytic cascade. These inflammasomes are therefore ideally positioned to mediate rapid responses to infection. Initiated within minutes of flagellin detection, the inflammasome-dependent eicosanoid production described here is one of the most rapid innate immune cellular responses known in vivo. Although performed in vivo, the results presented here rely on the systemic administration of toxins. It will be important to explore the role of inflammasome-dependent eicosanoids during live infection. When restricted to the site of infection, such eicosanoids may have a beneficial role in host defence, for example by rapidly increasing local vascular permeability, allowing an influx of antibody, j) measured by quantitative RT-PCR in BMDMs and resident peritoneal macrophages or thioglycollate-elicited peritoneal cells (thio.) sorted for CD11b/ F4-80 hi . k-n, Mice were injected intraperitoneally with FlaTox (k, l) or intravenously with anthrax lethal toxin (m, n; 200 mg PA 1 100 mg lethal factor); rectal temperature (k, m) and haematocrit (l, n) were measured after 30 min (k, l) or 45 min (m, n). k, l, B6;129P2-Cox1 2/2 mice and littermate controls. m, n, Cox-1 2/2 mice and littermate controls expressing a lethal-toxinsensitive (S) or resistant (R) Nlrp1b allele. Data are pooled from multiple experiments (k-n) or are representative of at least two (b, c, h-j) or three (a, d-g) independent experiments. Error bars in a, d and f-j denote s.e. Asterisk, P , 0.04; two asterisks, P , 0.006; three asterisks, P , 0.0007 (k-n, Mann-Whitney test; a, c, d, h-j, Student's t-test). Hash sign, not detected.
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complement and immune cells. Future studies should also evaluate a role for eicosanoids in other inflammasome-dependent phenotypes previously described in vivo. Indeed, our results suggest that the signalling outputs of inflammasomes may be much broader than has previously been realized.
METHODS SUMMARY
Toxin delivery and pathology. Recombinant proteins (PA, LFn-FlaA, LFn-FlaA(AAA) and LF) were purified from Escherichia coli as described previously 29 , and endotoxin was removed with Detoxi-Gel (Pierce). LFn-FlaA(AAA) was generated by mutating the three carboxy-terminal leucines of L. pneumophila flagellin to alanine 4 . Unless otherwise noted, standard toxin doses were 2 mg g 21 body weight of LFn-FlaA in vivo (200 ml intraperitoneally) and 5 mg ml 21 LFn-FlaA in vitro. PA dose was always 2 3 LFn-FlaA. Rectal temperature was measured with a MicroTherma 2T thermometer (Braintree Scientific). Blood for haematocrit was collected by retro-orbital bleed into StatSpin microhaematocrit tubes (Fisher Scientific). Mice. For bone marrow chimaeras, mice were irradiated twice with 600 rad 4 h apart, injected with 5 3 10 6 donor cells, and analysed after 12-15 weeks. Macrophages were depleted for 48 h with liposome-encapsulated clodronate (N.v.R) (500 ml intraperitoneally and 200 ml intravenously). CD11b 1 cells were depleted for 24 h in FVB-Tg(CD11b/EGFP)34Lan/J mice with 25 ng g 21 body weight (intraperitoneally) of diphtheria toxin (Sigma-Aldrich). Lipidomics. Lipid autacoids were extracted by solid phase with SampliQ ODS-C 18 cartridges (Agilent Technologies). Eicosanoids and docosanoids were identified and quantified with a triple-quadrupole linear ion-trap LC-MS/MS system (MDS SCIEX 3200 QTRAP) equipped with a Kinetex C 18 mini-bore column. Statistical analysis. Statistical differences were calculated with an unpaired twotailed Student's t-test (in vitro/ex vivo) or two-tailed non-parametric Mann-Whitney test (in vivo) using GraphPad Prism 4.0b.
